Not Yet RecruitingNot Applicable

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Italy40 participantsStarted 2026-06

Plain-language summary

This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers * Able to provide informed consent * Able to communicate in Italian Exclusion Criteria: * Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)

What they're measuring

Retention Fraction

Timeframe: 6 months

Trial details

NCT IDNCT07579065

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2028-01

Contact for this trial

Barbara Bressi

barbara.bressi@ausl.re.it

View on ClinicalTrials.gov More Hematologic Neoplasm trials